Concepedia

Publication | Open Access

Abiraterone and Increased Survival in Metastatic Prostate Cancer

DOIFull Paper Access

4.3K

Citations

40

References

2011

Year

Johann S. de Bono, Christopher J. Logothetis, Arturo Molina, Karim Fizazi, Scott North, Luis Chu, Kim N., Robert J. Jones, Oscar B. Goodman, Fred Saad,
New England Journal of Medicine

Abstract

The inhibition of androgen biosynthesis by abiraterone acetate prolonged overall survival among patients with metastatic castration-resistant prostate cancer who previously received chemotherapy. (Funded by Cougar Biotechnology; COU-AA-301 ClinicalTrials.gov number, NCT00638690.).

References

YearCitations

Page 1